Bosentan Hydrate

CAS No. 157212-55-0

Bosentan Hydrate( —— )

Catalog No. M12244 CAS No. 157212-55-0

Bosentan is a competitive and dual antagonist of endothelin-1 at the endothelin-A (ET-A) and endothelin-B (ET-B) receptors.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 55 In Stock
25MG 37 In Stock
50MG 51 In Stock
100MG 90 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Bosentan Hydrate
  • Note
    Research use only, not for human use.
  • Brief Description
    Bosentan is a competitive and dual antagonist of endothelin-1 at the endothelin-A (ET-A) and endothelin-B (ET-B) receptors.
  • Description
    Bosentan is a competitive and dual antagonist of endothelin-1 at the endothelin-A (ET-A) and endothelin-B (ET-B) receptors.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Endothelin Receptor
  • Recptor
    ET-B| ET-A
  • Research Area
    Cardiovascular Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    157212-55-0
  • Formula Weight
    569.63
  • Molecular Formula
    C??H??N?O?S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:93 mg/mL (163.3 mM);Ethanol:2 mg/mL (3.51 mM);Water:<1 mg/Ml
  • SMILES
    O.COC1=CC=CC=C1OC1=C(OCCO)N=C(N=C1NS(=O)(=O)C1=CC=C(C=C1)C(C)(C)C)C1=NC=CC=N1 |c:4,6,10,16,18,27,29,38,40,t:2,25,36|
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Clozel M, et al. J Pharmacol Exp Ther, 1994, 270(1), 228-235.
molnova catalog
related products
  • SB-209670

    SB-209670 is a selective endothelin receptor antagonist that inhibits the activity of ET(B) receptors in rat vascular endothelium and vascular smooth muscle.

  • Sarafotoxin S6c

    Highly selective ETB endothelin receptor agonist (Ki values are 0.29 and 28000 nM at ETB and ETA receptors respectively).

  • Ambrisentan

    Ambrisentan (BSF 208075;LU 208075) is a highly selective antagonist of the endothelin-1 type A receptor (ETA) for use in the treatment of pulmonary hypertension.